2BB score and signals
Adaptive Biotechnologies Corporation’s current 2BB score is 35 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 48 | Moderate |
| Momentum | 39 | Weakening |
| Financial strength | 30 | Weak |
| Quality | 96 | Very Strong |
| Risk | 34 | Low |
Company facts
| CEO | Chad Robins |
| Headquarters | Seattle, Washington, United States |
| Founded | 2009 |
| Employees | 624 |
| 52-week range | $12.00 – $30.74 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-03 | — | -0.0676 | — | $80.83M |
| 2026-11-05 | — | -0.102 | — | $73.07M |
| 2026-07-29 | — | -0.1364 | — | $67.20M |
| 2026-05-05 | -0.12 | -0.1632 | $70.87M | $62.07M |
Related companies
2BBBullish & Bearish